Gambaran Umum
Ang Burning Rock Biotech Limited ay isang kumpanyang naka-headquarter sa China, na pangunahing tumatakbo sa loob ng industriya ng biotechnology. Dalubhasa ang kumpanya sa mga solusyon sa precision oncology, na tumutuon sa mga diagnostic ng susunod na henerasyon na sequencing (NGS). Ang kanilang mga pangunahing proyekto ay nagsasangkot ng pagbuo at pagkomersyal ng isang hanay ng mga pagsubok at mga therapy na iniayon sa mga genetic na profile ng mga indibidwal na pasyente ng kanser. Ang Burning Rock Biotech ay malapit na nakikipagtulungan sa mga pandaigdigang kumpanya ng parmasyutiko at mga institusyong medikal upang isulong ang pagiging epektibo ng pananaliksik at paggamot sa kanser. Ang kanilang mga pagsusumikap ay higit na nakasentro sa pagbibigay ng komprehensibong genomic profiling na mga pagsubok upang matukoy ang mga mutasyon sa kanser, kaya pinapadali ang mga naka-target na desisyon sa therapy at pagpapabuti ng mga resulta ng paggamot para sa mga pasyente na may iba't ibang uri ng kanser.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah 523.28 MM.
- Nilai operating income untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -211.78 MM.
- Nilai net income untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -238.58 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-03-31 | 523.28 | -211.78 | -238.58 |
2024-12-31 | 515.82 | -322.43 | -346.63 |
2024-09-30 | 510.88 | -441.96 | -427.55 |
2024-06-30 | 509.81 | -582.18 | -566.78 |
2024-03-31 | 520.54 | -606.69 | -589.99 |
2023-12-31 | 537.43 | -669.32 | -653.69 |
2023-09-30 | 558.59 | -720.44 | -707.70 |
2023-06-30 | 585.65 | -776.27 | -764.20 |
2023-03-31 | 570.23 | -906.00 | -895.10 |
2022-12-31 | 563.24 | -980.41 | -971.23 |
2022-09-30 | 568.35 | -1,015.09 | -1,006.15 |
2022-06-30 | 540.33 | -951.49 | -945.15 |
2022-03-31 | 536.76 | -888.06 | -886.67 |
2021-12-31 | 507.86 | -797.06 | -796.70 |
2021-09-30 | 492.24 | -700.31 | -702.03 |
2021-06-30 | 489.50 | -653.91 | -658.68 |
2021-03-31 | 469.20 | -524.93 | -526.07 |
2020-12-31 | 429.90 | -412.40 | -407.24 |
2020-09-30 | 386.86 | -352.51 | -345.85 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | -41.63 | -41.63 |
2024-06-30 | -55.31 | -55.31 |
2024-03-31 | -57.60 | -57.60 |
2023-12-31 | -63.84 | -63.84 |
2023-09-30 | -69.12 | -69.12 |
2023-06-30 | -74.35 | -74.35 |
2023-03-31 | -86.58 | -86.58 |
2022-12-31 | -93.47 | -93.47 |
2022-09-30 | -96.35 | -96.35 |
2022-06-30 | -90.43 | -90.43 |
2022-03-31 | -84.99 | -84.99 |
2021-12-31 | -76.45 | -76.45 |
2021-09-30 | -67.41 | -67.41 |
2021-06-30 | -63.31 | -63.31 |
2021-03-31 | -63.86 | -63.86 |
2020-12-31 | -68.76 | -68.76 |
2020-09-30 | -92.37 | -92.37 |
2020-06-30 | -136.19 | -136.19 |
2020-03-31 | -144.83 | -144.83 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -75.58 MM.
- Nilai cash from investing activities untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -3.56 MM.
- Nilai kas dari aktivitas pendanaan untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -0.07 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-03-31 | -75.58 | -3.56 | -0.07 |
2024-12-31 | -92.26 | -4.41 | -0.07 |
2024-09-30 | -127.34 | -3.93 | -1.91 |
2024-06-30 | -144.48 | -4.93 | -47.80 |
2024-03-31 | -182.85 | -7.63 | -48.80 |
2023-12-31 | -255.78 | -9.30 | -48.83 |
2023-09-30 | -307.47 | -14.01 | -57.00 |
2023-06-30 | -395.52 | -32.17 | -13.78 |
2023-03-31 | -425.59 | 1.49 | -82.34 |
2022-12-31 | -456.81 | -7.46 | -86.24 |
2022-09-30 | -501.45 | -69.40 | -82.94 |
2022-06-30 | -499.38 | -121.34 | -113.27 |
2022-03-31 | -509.10 | -219.64 | -52.67 |
2021-12-31 | -477.89 | 81.70 | -52.90 |
2021-09-30 | -456.20 | 112.24 | 22.36 |
2021-06-30 | -359.85 | -181.05 | 34.41 |
2021-03-31 | -179.73 | 182.63 | 1,889.33 |
2020-12-31 | -73.54 | -109.31 | 2,165.72 |
2020-09-30 | -33.02 | -50.62 | 2,098.33 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.35.
- roe untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.48.
- roic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.55.
- croic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.15.
- ocroic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.15.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-03-31 | -0.35 | -0.48 | -0.55 | -0.15 | -0.15 |
2024-12-31 | -0.41 | -0.56 | -0.57 | -0.18 | -0.17 |
2024-09-30 | -0.49 | -0.66 | -0.72 | -0.25 | -0.18 |
2024-06-30 | -0.42 | -0.56 | -0.80 | -0.31 | -0.25 |
2024-03-31 | -0.45 | -0.61 | -0.80 | -0.43 | -0.35 |
2023-12-31 | -0.41 | -0.54 | -0.80 | -0.43 | -0.35 |
2023-09-30 | -0.41 | -0.53 | -0.77 | -0.42 | -0.40 |
2023-06-30 | -0.52 | -0.68 | -0.77 | -0.42 | -0.40 |
2023-03-31 | -0.46 | -0.59 | -0.82 | -0.43 | -0.39 |
2022-12-31 | -0.41 | -0.49 | -0.74 | -0.47 | -0.37 |
2022-09-30 | -0.39 | -0.46 | -0.74 | -0.47 | -0.37 |
2022-06-30 | -0.35 | -0.41 | -0.63 | -0.49 | -0.33 |
2022-03-31 | -0.30 | -0.34 | -0.51 | -0.48 | -0.29 |
2021-12-31 | -0.26 | -0.29 | -0.41 | -0.25 | -0.21 |
2021-09-30 | -0.25 | -0.26 | -0.32 | -0.19 | -0.16 |
2021-06-30 | -0.22 | -0.25 | -0.29 | -0.30 | -0.16 |
2021-03-31 | -0.49 | -0.59 | -0.21 | 0.71 | -0.07 |
2020-12-31 | -0.48 | -0.62 | -0.16 | 0.73 | -0.03 |
2020-09-30 | -0.13 | 0.74 | -0.01 | ||
2020-06-30 | -0.67 | -0.09 | 0.87 | -0.00 | |
2020-03-31 | -0.55 | -0.21 | -0.05 | -0.14 |
Gross Margins
- marjin kotor untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah 0.70.
- marjin bersih untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.67.
- marjin operasi untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.63.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-03-31 | 0.70 | -0.67 | -0.63 |
2024-12-31 | 0.69 | -0.84 | -0.87 |
2024-09-30 | 0.68 | -1.11 | -1.14 |
2024-06-30 | 0.67 | -1.13 | -1.17 |
2024-03-31 | 0.69 | -1.27 | -1.29 |
2023-12-31 | 0.69 | -1.27 | -1.29 |
2023-09-30 | 0.70 | -1.30 | -1.33 |
2023-06-30 | 0.67 | -1.30 | -1.33 |
2023-03-31 | 0.67 | -1.57 | -1.59 |
2022-12-31 | 0.68 | -1.77 | -1.79 |
2022-09-30 | 0.68 | -1.77 | -1.79 |
2022-06-30 | 0.70 | -1.75 | -1.76 |
2022-03-31 | 0.72 | -1.65 | -1.65 |
2021-12-31 | 0.73 | -1.57 | -1.57 |
2021-09-30 | 0.73 | -1.43 | -1.42 |
2021-06-30 | 0.73 | -1.35 | -1.34 |
2021-03-31 | 0.74 | -1.12 | -1.12 |
2020-12-31 | 0.73 | -0.95 | -0.96 |
2020-09-30 | 0.70 | -0.89 | -0.91 |
2020-06-30 | 0.70 | -0.68 | -0.71 |
2020-03-31 | 0.70 | -0.60 | -0.63 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1792267 |
Grupong Pang-industriya
SIC 8071 - Medical Laboratories |